@article{SchindkeGischGumz2021,
  author    = {Schindke, Corinna and Gisch, Ulrike Alexandra and Gumz, Antje},
  title     = {Wie sollte Yoga in der Therapie der Anorexia nervosa ausgef{\"u}hrt werden?},
  series = {Psychotherapie, Psychosomatik, medizinische Psychologie : PPmP ; Organ des Deutschen Kollegiums f{\"u}r Psychosomatische Medizin},
  volume    = {71},
  journal   = {Psychotherapie, Psychosomatik, medizinische Psychologie : PPmP ; Organ des Deutschen Kollegiums f{\"u}r Psychosomatische Medizin},
  number    = {11},
  publisher = {Thieme},
  address   = {Stuttgart},
  issn      = {0937-2032},
  doi       = {10.1055/a-1390-4450},
  pages     = {446 -- 455},
  year      = {2021},
  abstract  = {An altered interoception is a central correlate of anorexia nervosa (AN) and addressing this issue offers a promising approach in the treatment of AN. First results have shown the effectiveness of yoga as a body-focused intervention in the treatment of AN. However, to date there is a lack of empirical evidence regarding the question how yoga strategies and yoga elements (postures, relaxation, breath, meditation) should be applied. Against this background, we conducted a qualitative pilot study with n = 6 female patients with AN undergoing treatment in a specialist unit supporting re-insertion subsequent to a preceding inpatient AN treatment. Study participants received a weekly one-hour hatha-yoga intervention over at least 12 weeks. After the yoga intervention, semi-structured interviews (1/2 to 1 hour) were conducted to assess the experiences of the study participants during the yoga intervention. The data were analyzed using Grounded Theory. At the upper level of analysis, four categories were differentiated: information regarding 1) study participants' symptoms, 2) aspects of the setting experienced to be beneficial, 3) yoga strategies perceived to be beneficial and 4) perceived consequences of yoga strategies. With regard to the yoga strategies perceived to be beneficial, analyses revealed 4 subcategories: features of 1) postures and movements, 2) breath and meditation exercises, 3) relaxation exercises and 4) general information about the setting. The results give first indications regarding the conceptualization of yoga in the treatment of AN and potential mechanisms. Further qualitative and quantitative studies are needed, e.g., with regard to effectiveness, contraindications, mediators or moderators to better evaluate the potential of yoga in the treatment of AN.},
  language  = {de}
}
@article{SarrarHolzhausenWarschburgeretal.2016,
  author    = {Sarrar, Lea and Holzhausen, Martin and Warschburger, Petra and Pfeiffer, Ernst and Lehmkuhl, Ulrike and Schneider, Nora},
  title     = {Cognitive Function in Adolescent Patients with Anorexia Nervosa and Unipolar Affective Disorders},
  series = {European eating disorders review : the professional journal of the Eating Disorders Associatio},
  volume    = {24},
  journal   = {European eating disorders review : the professional journal of the Eating Disorders Associatio},
  publisher = {Wiley-Blackwell},
  address   = {Hoboken},
  issn      = {1072-4133},
  doi       = {10.1002/erv.2425},
  pages     = {232 -- 240},
  year      = {2016},
  abstract  = {Studies have shown impairments in cognitive function among adult patients with anorexia nervosa (AN) and affective disorders (AD). The association between cognitive dysfunctions, AN and AD as well as the specificity for these psychiatric diagnoses remains unclear. Therefore, we examined cognitive flexibility and processing speed in 47 female adolescent patients with AN, 21 female adolescent patients with unipolar affective disorders and 48 female healthy adolescents. All participants completed a neuropsychological test battery. There were no significant group differences regarding cognitive function, except for psychomotor processing speed with poorer performance in patients with AN. A further analysis revealed that all groups performed with the normal range, although patients with AN were over represented in the poorest performing quartile. We found no severe cognitive impairments in either patient group. Nevertheless, belonging to the AN group contributed significantly to poor performances in neuropsychological tasks. Therefore, we conclude that the risk for cognitive impairments is slightly higher for patients with AN. Copyright (c) 2015 John Wiley \& Sons, Ltd and Eating Disorders Association.},
  language  = {en}
}
@misc{SchleglDittmerHoffmannetal.2018,
  author    = {Schlegl, Sandra and Dittmer, Nina and Hoffmann, Svenja and Voderholzer, Ulrich},
  title     = {Self-reported quantity, compulsiveness and motives of exercise in patients with eating disorders and healthy controls},
  series = {Postprints der Universit{\"a}t Potsdam Mathematisch-Naturwissenschaftliche Reihe},
  journal   = {Postprints der Universit{\"a}t Potsdam Mathematisch-Naturwissenschaftliche Reihe},
  number    = {687},
  issn      = {1866-8372},
  doi       = {10.25932/publishup-42683},
  url       = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-426831},
  pages     = {10},
  year      = {2018},
  abstract  = {Background: Compulsive exercise (CE) is a frequent symptom in patients with eating disorders (EDs). It includes, in addition to quantitatively excessive exercise behaviour, a driven aspect and specific motives of exercise. CE is generally associated with worse therapy outcomes. The aims of the study were to compare self-reported quantity of exercise, compulsiveness of exercise as well as motives for exercise between patients with anorexia nervosa (AN), bulimia nervosa (BN) and healthy controls (HC). Additionally, we wanted to explore predictors of compulsive exercise (CE) in each group. Methods: We investigated 335 female participants (n = 226 inpatients, n = 109 HC) and assessed self-reported quantity of exercise, compulsiveness of exercise (Compulsive Exercise Test), motives for exercise (Exercise Motivations Inventory-2), ED symptoms (Eating Disorder Inventory-2), obsessive-compulsiveness (Obsessive-Compulsive Inventory-Revised), general psychopathology (Brief Symptom Inventory-18) and depression (Beck Depression Inventory-2). Results: Both patients with AN and BN exercised significantly more hours per week and showed significantly higher CE than HC; no differences were found between patients with AN and BN. Patients with EDs and HC also partly varied in motives for exercise. Specific motives were enjoyment, challenge, recognition and weight management in patients with EDs in contrast to ill-health avoidance and affiliation in HC. Patients with AN and BN only differed in regard to exercise for appearance reasons in which patients with BN scored higher. The most relevant predictor of CE across groups was exercise for weight and shape reasons. Conclusions: Exercise behaviours and motives differ between patients with EDs and HC. CE was pronounced in both patients with AN and BN. Therefore, future research should focus not only on CE in patients with AN, but also on CE in patients with BN. Similarities in CE in patients with AN and BN support a transdiagnostic approach during the development of interventions specifically targeting CE in patients with EDs.},
  language  = {en}
}
@phdthesis{Buerger2016,
  author    = {B{\"u}rger, Arne},
  title     = {MaiStep - Mainzer Schultraining zur Essst{\"o}rungspr{\"a}vention},
  url       = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-98369},
  school      = {Universit{\"a}t Potsdam},
  pages     = {IX, 160},
  year      = {2016},
  abstract  = {Objectives The aim of this doctoral thesis was to investigate the efficacy of a German skills-based primary prevention program for partial-syndrome and full-syndrome eating disorders (Mainzer Schultraining zur Essst{\"o}rungspr{\"a}vention (MaiStep)) in reducing eating disorder symptoms as the primary outcome and associated psychopathology as a secondary outcome. Design Randomized Controlled Trial (RCT), three-intervention-group design, with two intervention groups and one active control group with a 3-month and 12-month follow-up. Setting A project in nine schools within the state of Rhineland-Palatine, Germany; funded by the Ministry of Health and Social Affairs (MSAGD) and the Ministry of Education, Culture and Research (MBWWK). Participants 1,654 adolescents (female/male: 781/873; mean age: 13.1±0.7; BMI: 20.0±3.5) recruited from randomly selected schools. Interventions The implementation and development of the skills based program was based on a systematic review of 63 scientific articles regarding eating disorder prevention in childhood and adolescence. One intervention group was conducted by psychologists and one by trained teachers. The active control group was performed by trained teachers using a stress and addiction prevention program. Main outcome measures The primary outcome measure was the incidence of partial-syndrome and full-syndrome eating disorders after completion of the program; secondary outcomes included self-reported questionnaires about eating disorder pathology. Results MaiStep did not reveal significant group differences at 3-month follow-up but showed a significant difference between the intervention groups and the active control group for partial anorexia nervosa (CHI²(2)) = 8.74, p = .01**) and partial bulimia nervosa (CHI²(2) = 7.25, p = .02*) at 12-month follow-up. Consistent with the primary outcome, the secondary measures were even more effective in the intervention groups at 12-month follow-up. The subscales of the Eating Disorder Inventory (EDI-2) drive of thinness (F (2, 355) = 3.94, p = .02*) and perfectionism (F (2, 355) = 4.19, p = .01**) and the Body Image Avoidance Questionnaire (BIAQ) (F (2, 525) = 18.79, p = .01**) showed significant differences for the intervention groups and demonstrated the effectiveness of MaiStep. Conclusions MaiStep has shown to be a successful program to prevent eating disorders in adolescents at 13 to 15 years of age. In addition, MaiStep was equally effective when conducted by teachers compared to psychologists suggesting feasibility of implementation in real world settings. Trial registration MaiStep is registered at the German Clinical Trials Register (DRKS00005050).},
  language  = {de}
}